This award recognises ACEA Biosciences as the supplier with the largest percentage increase in Flow Cytometer citations over the past year. After gaining ‘Highly Commended’ in the awards last year, this really suggests the company might be about to take off in this market in a big way!

Founded in 2002, ACEA Biosciences, now part of Agilent Technologies, is a biotechnology company that is pioneering the development and commercialisation of high performance, cutting edge cell analysis instruments for life science research and clinical diagnostics.

ACEA aims to revolutionise the field of flow cytometry by designing and producing high performance, customisable benchtop cytometers at accessible price points. By including features such as 13 fluorescence detection channels with 3 lasers, direct volumetric based cell counting, and a versatile high throughput walkaway autosampler, ACEA’s line of NovoCyte® flow cytometers is raising the bar for what is expected of benchtop machines.

Dr Andrew Chalmers said: “Congratulations to ACEA Biosciences on winning Flow Cytometer Supplier to Watch in 2020. The company is clearly disrupting the Flow Cytometry market and we look forward to watching its progress over the next few years!”